ping an-杏耀平台代理注册

on april 28, 2011, c&o announced that it has been authorized by shionogi & co., ltd., a japanese pharmaceutical company, to be the exclusive distributor of flumarin®, an antibiotic of oxacephalosporins for injection, in china.

in march 2011, the high standard edaravone raw materials and injection developed by c&o was approved by sfda. edaravone is a neuroprotective agent, used to improve neurological symptoms, activities of daily living and functional impairment due to acu